← Back to patent-cliff list
Oxcarbazepine
Tier C — Watch / tradeOxcarbazepine
Novartis
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：SCNA
Brand：Epilexter, Epliga, Trileptal, Oxtellar XR
Indications (approved)：Seizure
Regional status
US
Approved
2000-01-14
EU
Discontinued
2002-06-01
China
Approved
2003-06-20
Japan
No progress
2009-09-01
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Oxcarbazepine?
Approved indications include: Seizure.
When does the Oxcarbazepine patent expire?
No public expiry year is available for Oxcarbazepine yet; this page updates once verified.
How do I get a quote for Oxcarbazepine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27